Association of thyroid autoimmunity with psoriasis

M. Abir Hassan; M. Qamrul Hassan Jaigirdar; Arjun Saha; Towfiq Ahmad; Tanzina Begum Chowdhury; Marufa Shahrin

doi:10.18203/2320-6012.ijrms20262167

Authors

M. Abir Hassan Department of Dermatology, Sir Salimullah Medical College, Dhaka, Bangladesh
M. Qamrul Hassan Jaigirdar Department of Dermatology, Bangladesh Medical University, Dhaka, Bangladesh
Arjun Saha Department of Dermatology and Venereology, Directorate General of Health Services (DGHS), Dhaka, Bangladesh
Towfiq Ahmad Department of Dermatology and Venereology, Rajshahi Medical College Hospital, Rajshahi, Bangladesh
Tanzina Begum Chowdhury Department of Dermatology and Venereology, Sarkari Karmachari Hospital, Dhaka, Bangladesh
Marufa Shahrin Department of Dermatology and Venereology, Directorate General of Health Services (DGHS), Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20262167

Keywords:

Autoimmune thyroid disease, Anti-thyroglobulin antibody, Anti-thyroid peroxidase antibody, Psoriasis, Thyroid autoimmunity

Abstract

Background: Psoriasis is a chronic, relapsing, multifactorial inflammatory disorder of the skin. Psoriasis has been found to be associated with different autoimmune disorders; autoimmune thyroid disorder is one of them. Several studies have suggested an association of thyroid autoimmunity with psoriasis.

Methods: A total of 63 patients with psoriasis and equal number of age and sex matched apparently healthy subjects were included. Psoriasis area and severity index (PASI) score was calculated. Free triiodothyronine (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH), antithyroglobulin (AbTG), antithyroidperoxidase antibody (AbTPO) and TSH receptor Ab levels were measured in all of the subjects.

Results: The mean age of psoriasis patients was 35.8±16.7 years compared to 35.4±16.9 years in the control group and was found non-significant (p=0.899). Psoriasis group consisted of 63.5% males and 36.5% females, while the control group had 66.7% males and 33.3% females (p=0.709). Majority of psoriasis patients and control subjects were euthyroid (87.3% and 96.8% respectively). Anti TPO antibodies were elevated in 34.9% psoriasis patients compared to 4.8% in control group which was statistically significant (p<0.001). Anti TG Antibodies were elevated in 46.0% psoriasis patients compared to 7.9% in control group and was statistically significant (p<0.001).

Conclusions: This study showed significantly higher frequency of elevated anti TPO antibodies and anti-thyroglobulin (TG) antibodies in psoriasis patients compared to control group. So, there is association between thyroid autoimmunity and psoriasis. However, further large-scale studies are required to expand our knowledge about thyroid autoimmunity and its association with psoriasis.

References

Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-85.

Rigopoulos D, Gregoriou S, Katrinaki A, Korfitis C, Larios G, Stamou C, et al. Characteristics of psoriasis in Greece: an epidemiological study of a population in a sunny Mediterranean climate. Eur J Dermatol. 2010;20(2):189-95.

Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am. 1997;26(1):189-218.

Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):264-72.

Fukuma N, McLachlan SM, Rapoport B. Thyroid autoantigens and human T cell responses. Clin Exp Immunol. 1990;82(2):275-83.

Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174-80.

Hesarghatta Shyamasunder A, Abraham P. Measuring TSH receptor antibody to influence treatment choices in Graves' disease. Clin Endocrinol (Oxf). 2017;86(5):652-7.

Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves' disease. J Clin Invest. 2005;115(8):1972-83.

Franco JS, Amaya-Amaya J, Anaya JM. Autoimmunity. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R, editors. Autoimmunity: From Bench to Bedside. Bogota: El Rosario University Press; 2013. Available at: https://www.ncbi.nlm.nih.gov/books/NBK459466/. Accessed on 15 March 2026.

Lai YC, Yew YW. Psoriasis and thyroid profile: analysis of the US National Health and Nutrition Examination Survey database. Indian J Dermatol Venereol Leprol. 2016;82(3):310-2.

Gul U, Gonul M, Kaya I, Aslan E. Autoimmune thyroid disorders in patients with psoriasis. Eur J Dermatol. 2009;19(3):221-3.

Robati RM, Toossi P, Rahmati-Roodsari M, Khalilazar S, Abolhasani E, Namazi N, et al. Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment. Scient World J. 2013;2013:921819.

Vassilatou E, Papadavid E, Papastamatakis P, Alexakos D, Koumaki D, Katsimbri P, et al. No association of psoriasis with autoimmune thyroiditis. J Eur Acad Dermatol Venereol. 2017;31(1):102-6.

Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25(4):388-92.

Liang YL, Wu H, Shen X, Li PQ, Yang XQ, Liang L, et al. Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis. Mol Biol Rep. 2012;39(9):8873-82.

Alidrisi HA, Al Hamdi K, Mansour AA. Is there any association between psoriasis and Hashimoto's thyroiditis? Cureus. 2019;11(3):e4269.

Kiguradze T, Bruins FM, Guido N, Bhattacharya T, Rademaker A, Florek AG, et al. Evidence for the association of Hashimoto's thyroiditis with psoriasis: a cross-sectional retrospective study. Int J Dermatol. 2017;56(5):553-6.

Wang SH, Wang J, Lin YS, Tung TH, Chi CC. Increased risk for incident thyroid diseases in people with psoriatic disease: a cohort study. J Am Acad Dermatol. 2019;80(4):1006-12.

Hancer H, Alatas E. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio relationship with disease severity and metabolic syndrome in patients with psoriasis vulgaris. Ann Med Res. 2020;27(10):2503-9.

Mahrous EAM. The relationship between platelet volume and risk of atherosclerosis in patients with psoriasis. Egypt J Dermatol Venerol. 2018;38:29-36.

Alakbarov H, Sağduyu İE, Acar A, Türk BG, Ünal İ. Age distribution of psoriasis clinical types: a single center study. Turkderm Turk Arch Dermatol Venereol. 2021;55:193-8.

Kim DS, Lee J, Kim SH, Kim SM, Lee MG. Mean platelet volume is elevated in patients with psoriasis vulgaris. Yonsei Med J. 2015;56(3):712-8.

Yumnam D, Kansal NK, Kant R. Association of psoriasis with thyroid disorders: a hospital-based, cross-sectional study. Cureus. 2022;14(3):e22987.

Arican O, Bilgic K, Koc K. The effect of thyroid hormones in psoriasis vulgaris. Indian J Dermatol Venereol Leprol. 2004;70(6):353-6.